The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Addictions Therapeutics Global Market Report 2023, the addictions therapeutics market is expected to show significant growth in the forecast period.

Key insights from the addictions therapeutics market forecast include:

1. Market Size

According to The Business Research Company, the global addictions therapeutics market will increase from $6.12 billion in 2022 to $6.56 billion in 2023, with a 7.1% CAGR. By 2027, it is estimated to reach $8.29 billion at a 6% CAGR.

2. Major Driver

Rising alcohol consumption is set to drive the addiction therapeutics market. For example, data from the Australian Institute of Health and Welfare reveals a significant increase in alcohol sales in Australia, growing from $999 billion in March 2019 to $1,318.7 billion in March 2020. Additionally, between the 2020 and 2021 calendar years, alcohol sales rose from $12,334.1 billion to $15,625.2 billion, reinforcing the market’s growth due to increased alcohol consumption.

View More On The Addictions Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

3. Key Trend

Product innovations are a significant trend in the addiction therapeutics market. Leading companies are creating advanced products to maintain their market position. For example, in May 2020, Hikma Pharmaceuticals, a UK-based pharmaceutical manufacturer, introduced Naloxone Hydrochloride Injection, USP, 2 mg/2 mL in a prefilled syringe (PFS) for the rapid and precise emergency treatment of known or suspected opioid overdoses. The Naloxone hydrochloride injection PFS is ready-to-use, improving treatment speed and safety, especially in critical situations like opioid overdoses.

4. Largest Region

North America was the largest region in the addictions therapeutics market in 2022.

5. Major Players

Major players in the addictions therapeutics market are Pfizer Inc., Novartis AG, GlaxoSmithKline plc, Gilead Sciences Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Insys Therapeutics Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Alchem International Ltd, Avalo Therapeutics Inc., Braeburn Inc., Titan Pharmaceuticals Inc., and BioCorRx Inc.

Request A Sample Of The Global Addictions Therapeutics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12129&type=smp

Key Addictions Therapeutics Market Segments
The global addictions therapeutics market is segmented –
1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs
2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment
3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center
4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel
5) By Application: Public, Private, Government

The Addictions Therapeutics Global Market Report 2023  provides an in-depth analysis on the addictions therapeutics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the addictions therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
CAR-T Therapy Global Market Report 2023
Rituximab Biosimilars Global Market Report 2023
Point-Of-Care Diagnostics Devices And Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model